Haemonetics Corp (NYSE:HAE)
$ 83.51 -1.75 (-2.05%) Market Cap: 4.19 Bil Enterprise Value: 5.21 Bil PE Ratio: 34.65 PB Ratio: 4.79 GF Score: 76/100

Haemonetics Corp at Citi Unplugged Medtech and Life Sciences Access Day Transcript

Feb 29, 2024 / 01:45PM GMT
Release Date Price: $72.98 (-2.52%)
Joanne Wuensch
Citi - Analyst

Good morning, everybody. We're chuckling along here at the 2024 Citi Unplugged Conference. And thank you very much, everyone, who's attending virtually or in the room. The next presentation is for Haemonetics. Thrilled to have Chris Simon here, and he also brought other members of the team, so you're well staffed.

Chris Simon
Haemonetics Corp - President and Chief Executive Officer

Yes.

Questions & Answers

Joanne Wuensch
Citi - Analyst

But anyway, I wanted to just kick it off high level for investors who are new to the company, what would you tell somebody that reached you on the street and said, hey, Chris, what are you doing?

Chris Simon
Haemonetics Corp - President and Chief Executive Officer

Thanks for that, Joanne. So my remarks will include some forward-looking statements. So the typical Safe Harbor applies. Haemonetics has three businesses: plasma, blood center, and hospital. First two are focused on collecting plasma

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot